首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷藥物遞輸設備電子醫療設備內視鏡檢查設備

市場調查報告書

商品編碼

1544188

智慧藥丸市場規模、佔有率和成長分析：按應用、目標領域、最終用戶、地區 - 產業預測，2024-2031 年

Smart Pills Market Size, Share, Growth Analysis, By Application (Capsule Endoscopy, Vital Sign Monitoring), By Target Area (Esophagus, Small Intestine), By End User (Hospitals, Diagnostic Centers), By Region - Industry Forecast 2024-2031

出版日期: 2024年08月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球智慧藥丸市場規模為47億美元，從2023年的53.2億美元成長到2031年的139.5億美元，預計在預測期間（2024-2031年）複合年成長率為12.8%。

全球智慧藥丸市場正在迅速發展，具有改變醫療保健的巨大潛力。智慧藥丸，也稱為數位藥丸或可攝入感測器，是嵌入小型電子設備的膠囊，吞服後可以在體內進行即時監控和資料傳輸。這些創新錠劑旨在透過改善診斷和最佳化治療結果來增強患者護理。其目標是彌合醫療技術和患者監測之間的差距，為管理各種健康狀況提供非侵入性且便捷的解決方案。智慧藥丸可以追蹤用藥依從性、監測生命徵象、檢測異常情況並將關鍵資料即時發送給醫療專業人員。有幾個因素正在推動智慧藥丸市場的成長，使其成為一個令人興奮的領域。心血管疾病、糖尿病、胃腸道疾病等慢性疾病的增加需要持續監測和及時干預。智慧藥丸為疾病管理和早期發現併發症提供了新方法，從而改善了患者的治療效果。此外，不斷成長的老年人口和對遠端患者監護的需求正在刺激智慧藥丸的採用。微電子和無線通訊的技術進步正在改善智慧藥丸的功能。改進的感測器和連接性使得全面的生理資料收整合為可能，例如溫度、pH 水平和藥物釋放模式，從而促進準確的診斷和個人化治療。儘管潛力巨大，但該市場仍面臨隱私問題、監管障礙、高成本以及醫療保健專業人員和患者意識有限等挑戰。然而，人工智慧 (AI) 和機器學習與智慧藥丸的融合等新趨勢為即時資料分析和個人化治療提供了機會。製藥公司、技術公司和醫療保健提供者之間的合作也正在推動創新和產品開發。這些發展為相關人員提供了加強藥物開發、最佳化臨床試驗、降低醫療成本以及改善病人參與和結果的機會。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Medtronic PLC（Ireland）
Proteus Digital Health Inc.（US）
CapsoVision Inc.（US）
Olympus Corporation（Japan）
Medisafe（US）
Bio-Images Research Limited（UK）
BodyCap（France）
Given Imaging Ltd.（Israel）
Philips Healthcare（Netherlands）
Medimetrics Personalized Drug Delivery BV（Netherlands）
PENTAX Medical（Japan）
Proteus Biomedical（US）
Check-Cap Ltd.（Israel）
Smart Pill Corporation（US）
IntroMedic Co. Ltd.（South Korea）
Acamp AG（Switzerland）
Olympus Medical Systems Corporation（Japan）
Medisim Ltd.（Israel）
Medtronic Inc.（US）
Medimetrics SA（Belgium）

簡介目錄

Product Code: SQMIG35I2313

Global Smart Pills Market size was valued at USD 4.7 billion in 2022 and is poised to grow from USD 5.32 billion in 2023 to USD 13.95 billion by 2031, at a CAGR of 12.8% during the forecast period (2024-2031).

The Global Smart Pills Market is rapidly advancing and holds significant potential to transform healthcare. Also known as digital pills or ingestible sensors, smart pills are capsules embedded with tiny electronic devices that, once swallowed, enable real-time monitoring and data transmission from within the body. These innovative pills are designed to enhance patient care by improving diagnosis and optimizing treatment outcomes. Their purpose is to bridge the gap between medical technology and patient monitoring, offering a non-invasive and convenient solution for managing various health conditions. Smart pills can track medication adherence, monitor vital signs, detect abnormalities, and send crucial data to healthcare professionals in real time. Several factors are driving the growth of the smart pills market, making it an exciting field. The increasing prevalence of chronic diseases like cardiovascular disorders, diabetes, and gastrointestinal conditions necessitates continuous monitoring and timely intervention. Smart pills provide a novel method for disease management and early detection of complications, improving patient outcomes. Additionally, the growing elderly population and the demand for remote patient monitoring are fueling the adoption of smart pills, which help reduce hospital visits and support independent living. Technological advancements in microelectronics and wireless communication have enhanced smart pills' capabilities. Improved sensors and connectivity allow for comprehensive physiological data collection, such as temperature, pH levels, and drug release patterns, facilitating precise diagnosis and personalized treatment. Despite their potential, the market faces challenges like privacy concerns, regulatory hurdles, high costs, and limited awareness among healthcare professionals and patients. However, emerging trends such as integrating artificial intelligence (AI) and machine learning with smart pills offer opportunities for real-time data analysis and personalized care. Collaborations between pharmaceutical companies, technology firms, and healthcare providers are also driving innovation and product development. These developments present opportunities for stakeholders to enhance drug development, optimize clinical trials, reduce healthcare costs, and improve patient engagement and outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Pills market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Pills Market Segmental Analysis

Global smart pills market is segmented on the application, target area, end-user and region. Based on application, the market is segmented into capsule endoscopy, targeted drug delivery, and vital sign monitoring. Based on target area, the market is segmented into esophagus, small intestine, large intestine, and stomach. Based on end-users, the market is segmented into hospitals, diagnostic centers, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Smart Pills Market

The increasing prevalence of gastrointestinal disorders, including Crohn's disease, irritable bowel syndrome (IBS), and colon cancer, is a key driver for the smart pills market. Smart pills equipped with advanced sensors can offer real-time insights into the digestive system, facilitating early diagnosis, personalized treatment, and enhanced patient outcomes. As gastrointestinal diseases become more widespread globally, smart pills provide a valuable tool for detecting abnormalities, monitoring disease progression, and administering targeted therapies in a non-invasive and patient-friendly way. This capability is crucial for improving the management of these conditions and addressing the growing healthcare needs associated with gastrointestinal health.

Restraints in the Global Smart Pills Market

The high cost of smart pills is a major barrier to their widespread adoption. The sophisticated technologies and manufacturing processes required to produce these pills result in higher prices compared to traditional diagnostic methods. This cost issue can restrict the accessibility of smart pills, especially in developing regions with limited healthcare resources. The expense associated with smart pills presents challenges related to affordability and reimbursement, potentially making it difficult for patients in certain areas or with constrained financial means to benefit from this advanced diagnostic technology.

Market Trends of the Global Smart Pills Market

A key trend in the smart pills market is the integration of AI algorithms and data analytics. Utilizing machine learning and advanced data analysis techniques, smart pills can deliver valuable insights, recognize patterns, and support predictive diagnostics, thereby improving the accuracy and efficiency of disease detection and monitoring. Smart pills equipped with AI capabilities can analyze real-time data from the digestive system, identify anomalies or disease markers, and offer actionable insights to healthcare providers. This integration enables early intervention and personalized treatment, enhancing overall patient care.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Degree Of Competition
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
Technology Analysis
Supply Chain Analysis
Patent Analysis
Pricing Analysis
Consumer Analysis
Pipeline Analysis

Global Smart Pills Market By Application

Market Overview
Capsule Endoscopy
Targeted Drug Delivery
Vital Sign Monitoring

Global Smart Pills Market By Target Area

Market Overview
Esophagus
Small Intestine
Large Intestine
Stomach

Global Smart Pills Market By End-User

Market Overview
Hospitals
Diagnostic Centers
Others

Global Smart Pills Market Size By Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proteus Digital Health Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CapsoVision Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medisafe (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Images Research Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BodyCap (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Given Imaging Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medimetrics Personalized Drug Delivery B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PENTAX Medical (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proteus Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Check-Cap Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smart Pill Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IntroMedic Co. Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acamp AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medisim Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medimetrics S.A. (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments